Arterial Hypertension in Pregnant Woman
DOI:
https://doi.org/10.24950/rspmi.537Keywords:
Eclampsia, Heart Disease Risk Factors, Hypertension, Pregnancy, Pre-EclampsiaAbstract
Hypertensive disorders of pregnancy continue to be a
cause of maternal and fetal morbidity and mortality, not only
in pregnancy and peripartum but also in the future life of
the mother and baby. It is essential not only to understand
the underlying pathophysiological mechanisms, but also to
know how to make the diagnosis with the appropriate methodology, assess the woman’s risk, and know the particular therapeutic options. Surveillance takes into account
the various types of hypertensive disorders, as the risk of
progression to potentially serious and/or fatal conditions
can have catastrophic consequences. This article seeks to
review arterial hypertension in pregnant woman in all fundamental aspects, for the most appropriate approach from the
internist’s point of view.
Downloads
References
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165-241. doi: 10.1093/eurheartj/ehy340.
Bramham K, Parnell B, Nelson-Piercy C, Seed P T, Poston L, Chappell L C et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis BMJ 2014; 348: g2301 doi:10.1136/bmj.g2301
McLaughlin K et al. Phenotypes of Pregnant Women who subsequently Develop Hypertension in Pregnancy. Journal of the American Heart Association. 2018;7:e009595. doi: 10.1161/JAHA.118.009595
Marilucy Lopez-Sublet, Bernard Lévy. Pré-éclampsie : maladie vasculaire majeure, physiopathologie, développements récents. Sang Thrombose Vaisseaux. 2018;30(4):161-9. doi:10.1684/stv.2018.1031
Brouwers L, van der Meiden-van Roest AJ, Savelkoul C, Vogelvang TE, Lely AT, Franx A, van Rijn BB. Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta- -analysis. BJOG. 2018. doi: 10.1111/1471-0528.15394.
Cífková R, Johnson MR, Kahan T, Brguljan J, Williams B, Coca A, et al. Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension. Eur Heart J Cardiovasc Pharmacother. 2020. doi: 10.1093/ehjcvp/pvz082.
Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, Rana S, et al. American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease, Kidney in Heart Disease Science Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022. doi: 10.1161/HYP.0000000000000208.
Chahine KM, Sibai BM. Chronic Hypertension in Pregnancy: New Concepts for Classification and Management. Am J Perinatol. 2019:161-168. doi: 10.1055/s-0038-1666976.
Paauw ND, Lely AT. Cardiovascular Sequels During and After Preeclampsia. Advances in Experimental Medicine and Biology. 2018;1065:455-470. doi: 10.1007/978-3-319-77932-4_28.
Stanhewicz AE. Residual vascular dysfunction in women with a history of preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2018; 315:R1062- -R1071. doi: 10.1152/ajpregu.00204.2018.
Odigboegwu O, Pan LJ, Chatterjee P. Use of Antihypertensive Drugs During Preeclampsia. Front Cardiovasc Med. 2018;5:50. doi: 10.3389/ fcvm.2018.00050.
Armaly Z, Jadaon JE, Jabbour A and Abassi ZA Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches. Front Physiol. 2018 9:973. doi: 10.3389/fphys.2018.00973
Novelli GP, Vasapollo B, Valensise H. Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream that is Coming True. J Am Heart Assoc. 2018, 7:e010084. doi: 10.1161/JAHA.118.010084
Ramlakhan KP, Johnson MR, Roos-Hesselink JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol. 2020;17:718-31. doi: 10.1038/s41569- 020-0390-z.
Alan T, Tita MD, Ph D, Jeff M, Szychowski et al. for the Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension during Pregnancy. NEJM 2022; 386:1781-1792. doi: 10.1056/NEJMoa2201295.
Shekhar S, Gupta N, Kirubakaran R, Pareek P. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematicreview and meta-analysis. BJOG. 2016;123:40-7. doi: 10.1111/1471- 0528.13463.
Yin J, Mei Z, Shi S, Du P, Qin S. Nifedipine or amlodipine? The choice for hypertension during pregnancy: a systematic review and meta-analysis. Arch Gynecol Obstet. 2022 (in press). doi: 10.1007/s00404-022-06504-5.
Timpka, S., Fraser, A., Schyman, T. et al. The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women. Eur J Epidemiol. 2018; 33: 1003–10 . doi: 10.1007/ s10654-018-0429-1
Theilen LH. Preeclampsia and cardiovascular risk: comparing apples to apples. Mini-commentary. BJOG. 2018;125:1655. doi: 10.1111/1471- 0528.15425.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Medicina Interna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
